HIV and AIDS Trial, Recruiting (NCT05260307)

HIV and AIDS Trial, Recruiting NCT05260307 Sponsor: Boston University Charles River Campus Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT05260307 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with normal hearing:

Adults between 18 and 35 years old
Hearing test results showing no hearing loss across a standard range of sound frequencies
Able to give informed consent and follow experimental instructions
Normal vision, or vision that is fully corrected with glasses or contact lenses

For people with hearing loss:

Adults between 18 and 80 years old
A confirmed diagnosis of sensorineural hearing loss (a type of hearing loss affecting the inner ear or auditory nerve)
Able to give informed consent and follow experimental instructions
Normal vision, or vision that is fully corrected with glasses or contact lenses

Who may not be able to join:

People whose first language is not English may not be eligible for some parts of the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Virginia A Best, PhD, Boston University

Phone: (617) 353-2622

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05260307

Sponsor: Boston University Charles River Campus

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: (617) 353-2622

More information: https://clinicaltrials.gov/study/NCT05260307

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with normal hearing:

Adults between 18 and 35 years old
Hearing test results showing no hearing loss across a standard range of sound frequencies
Able to give informed consent and follow experimental instructions
Normal vision, or vision that is fully corrected with glasses or contact lenses

For people with hearing loss:

Adults between 18 and 80 years old
A confirmed diagnosis of sensorineural hearing loss (a type of hearing loss affecting the inner ear or auditory nerve)
Able to give informed consent and follow experimental instructions
Normal vision, or vision that is fully corrected with glasses or contact lenses

Who may not be able to join:

People whose first language is not English may not be eligible for some parts of the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Boston University Charles River Campus

Registry

ClinicalTrials.gov

Start date

9 March 2022

Est. completion

30 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Speech intelligibility at baseline; Speech intelligibility post-intervention; Speech reception threshold at baseline; Speech reception threshold post-intervention; Interaural time difference discrimination at baseline; Interaural time difference discrimination post-intervention; Externalization rating at baseline; Externalization rating post-intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov